Self-reported Prostate Cancer Progression Status Is Accurate: A Validation Study.

ABSTRACT:

Background

Studies of prostate cancer progression are important for discovering risk factors that may increase the risk of prostate cancer-specific death; however, little is known about the validity of self-reported prostate cancer progression.

Methods

We conducted a validation study of self-reported prostate cancer progression in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and in a prostate cancer cohort enrolled in a Fred Hutchinson Cancer Research Center (FHCRC)-based study. We calculated measures of validity for self-reported progression, including sensitivity, specificity, positive predictive value, and negative predictive value using medical records as the gold standard.

Results

Our results suggest that ascertaining prostate cancer

SUBMITTER: Daugherty SE 

PROVIDER: S-EPMC10389062 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature